No Result

View All Result

No products in the cart.

Home StudyGraphics

#VisualAbstract Molecular Guided Therapy Improves Survival for Unfavourable Cancer of Unknown Origin

byAngel GaoandAlisha Yi

August 20, 2024

in StudyGraphics

Reading Time: 1 min read

Click here to read this study in Lancet.

©2024 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc

RELATED REPORTS

Cognitive behaviour therapy may be superior to bright light therapy for insomnia in women with breast cancer undergoing chemotherapy

Tumour microenvironment factors may influence cancer progression and response to tamoxifen (Nolvadex) in patients with estrogen receptor-positive and human epidermal growth factor receptor 2 breast cancer

Perioperative toripalimab improves event-free survival in non-small cell lung cancer

The Scan by 2 Minute Medicine®: Competition and COVID, Anti-Anaphylaxis, Pulling the Plug on Psychedelics and POTS in the Pool:

RelatedReports

Sleep duration, sleepiness, chronotype have variable associations with teen self-regulation

Chronic Disease

Cognitive behaviour therapy may be superior to bright light therapy for insomnia in women with breast cancer undergoing chemotherapy

September 3, 2026

Variability in interpretation of breast biopsy slides associated with low verification of atypia and ductal carcinoma in situ

Chronic Disease

Tumour microenvironment factors may influence cancer progression and response to tamoxifen (Nolvadex) in patients with estrogen receptor-positive and human epidermal growth factor receptor 2 breast cancer

August 13, 2026

Nivolumab may be effective in platinum-resistant ovarian cancer

Surgery

Perioperative toripalimab improves event-free survival in non-small cell lung cancer

August 9, 2026

Adalimumab aids in control of noninfectious uveitis

Chronic Disease

Younger age and systemic metastases may independently predict survival among patients with choroidal metastases

August 3, 2026

#VisualAbstract: Site-Specific Therapy Guided by a 90-Gene Expression Assay Improved Survival in Patients with Cancer of Unknown Primary

Combined MRI and NIH stroke scores may predict stroke prognosis

uniQure: AMT-130 Gene Therapy Slows Progression of Huntington's Disease

#VisualAbstract: Impact of a community health worker led intervention for improved blood pressure control

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

No Result

View All Result

#VisualAbstract Molecular Guided Therapy Improves Survival for Unfavourable Cancer of Unknown Origin

Cognitive behaviour therapy may be superior to bright light therapy for insomnia in women with breast cancer undergoing chemotherapy

Tumour microenvironment factors may influence cancer progression and response to tamoxifen (Nolvadex) in patients with estrogen receptor-positive and human epidermal growth factor receptor 2 breast cancer

Perioperative toripalimab improves event-free survival in non-small cell lung cancer

The Scan by 2 Minute Medicine®: Competition and COVID, Anti-Anaphylaxis, Pulling the Plug on Psychedelics and POTS in the Pool:

#VisualAbstract: Site-Specific Therapy Guided by a 90-Gene Expression Assay Improved Survival in Patients with Cancer of Unknown Primary

RelatedReports

Cognitive behaviour therapy may be superior to bright light therapy for insomnia in women with breast cancer undergoing chemotherapy

Tumour microenvironment factors may influence cancer progression and response to tamoxifen (Nolvadex) in patients with estrogen receptor-positive and human epidermal growth factor receptor 2 breast cancer

Perioperative toripalimab improves event-free survival in non-small cell lung cancer

Younger age and systemic metastases may independently predict survival among patients with choroidal metastases

#VisualAbstract: Site-Specific Therapy Guided by a 90-Gene Expression Assay Improved Survival in Patients with Cancer of Unknown Primary

uniQure: AMT-130 Gene Therapy Slows Progression of Huntington's Disease

#VisualAbstract: Impact of a community health worker led intervention for improved blood pressure control

2MM+ All Access

Recent Reports

The medical literature, distilled daily.

Membership benefits